Background/Aims: Recent genomic medicine initiatives underscore the importance of including diverse participants in research. Considerable literature has identified barriers to and facilitators of increasing diversity, yet disparities in recruiting and retaining adequate numbers of participants from diverse groups continue to limit the generalizability of clinical genomic research. Methods: The North Carolina Clinical Genomic Evaluation by Next-gen Exome Sequencing study employed evidence-based strategies to enhance the participation of under-represented minority patients. In this study, we evaluate the impact of our efforts by systematically analyzing the "cascade" of attrition of participants throughout study interactions. Results: Although successful in recruiting a cohort that included ~30% non-Caucasian patients overall, the study still enrolled and retained a lower proportion of minorities compared to the pool of eligible patients who were nominated. We evaluated sociodemographic characteristics and related variables as potential factors associated with attrition throughout these phases of the study. Conclusions: These results suggest that varied approaches will be needed to increase participation in genomic medicine research. Our findings highlight factors to consider when developing strategies to address this critical need. Failing to include a broad range of populations in research studies will exacerbate existing disparities in the translation of genomic sequencing to medical care.
tests and treatments [2] and thereby guides changes to health policy and clinical care to advance social justice. Despite substantial efforts, failure to achieve robust inclusion of minorities is well documented throughout clinical research portfolios [3] , creating deficits in scientific knowledge, which in turn biases or limits conclusions that can be drawn and undermines efforts to reduce health disparities. Lack of diversity may have additional implications for genomic research, where understanding variation across populations is critical for the accurate interpretation of findings [4, 5] . The Precision Medicine Initiative (now referred to as the "All of Us" cohort; https://allofus.nih.gov/) aims to generate data about individual variation in predisposition to disease and treatment responses, and proposes to recruit participants who "broadly reflect" the diversity of the United States.
An extensive literature has identified barriers to inclusion in research [3, 6 ] including individual and systemlevel barriers [7, 8] . Common barriers include distrust of the medical care system and researchers, potential for stigma and discrimination, and lack of access to information, which can be related to language barriers and low literacy. Logistical barriers related to the location of clinical research sites, day/time restrictions on when research interactions occur, and out-of-date contact information are also common [3, 6, 9, 10] . Enrollment of minority participants can be facilitated by developing study designs and participation benefits that are informed by participant expectations, such as improved health care access and adequate remuneration [3, 6, 11] . Johnson and colleagues identified several factors associated with increased enrollment and retention of African American adults in genomic research, including the use of informal contacts for recruitment and employment of recruiters of like ancestry [4] . Considering potential barriers and facilitators, some factors may be more amenable to modification by the study team than others.
The North Carolina Clinical Genomic Evaluation by the Next-generation Exome Sequencing (NCGENES) study explored the implementation of genome-scale sequencing in adult and child patients with conditions suspected to have a genetic cause. NCGENES participants underwent exome sequencing with focused analysis of clinically relevant genes and disclosure of diagnostic results and medically actionable secondary findings. Adult patients and caregivers of child or cognitively impaired adult patients also completed telephone surveys and questionnaires that assessed their understanding of and responses to genomic results. In order to identify challenges to the clinical implementation of this testing in diverse groups, a major aim of the study was to describe if and how perceptions, use, and knowledge of testing results differed among previously under-represented North Carolina populations.
NCGENES employed specific, evidence-based strategies to enhance the enrollment of under-represented minority patients. To evaluate this goal, we analyzed a cascade of 4 study events; nomination, approached for recruitment, enrollment, and retention. We then investigated sociodemographic characteristics and factors potentially associated with each step of this cascade. We anticipated that these evidence-based strategies would improve the representativeness of participants in genomic research, and highlight the importance of systematically monitoring recruitment and retention of study participants in order to achieve a diverse study sample.
Methods

Procedures
The study examined all nominated patients to identify where attrition occurred at each stage of the cascade (described in depth in Fig. 1 ). Nominations could occur through a clinical encounter during which the provider notified the potential participant about the study, or through the review of independently maintained clinic databases or relevant diagnostic codes in medical records data. Eligible participants were either notified about the study directly by their clinical provider, or through a mailed "optout" letter that described the study and provided a postcard that could be returned to decline any further contact from the study. For the present analysis, participants were classified as either "adults" (cognitively intact patients aged 18 or older who provided consent, underwent sequencing, and completed surveys about their own understanding of and experiences with genomic sequencing) or "caregivers" (parents or guardians aged 18 or older who provided consent for a child or cognitively impaired adult patient to undergo sequencing, and who completed surveys about parental understanding of and experiences with genomic sequencing). Retention corresponded with enrolled participants who completed the study activities described in Figure 1 . Telephone surveys accounted for 2 of the 4 required study activities (content detailed in online suppl. Table 1 ; for all online suppl. material, see www.karger.com/doi/10.1159/000490519). The Institutional Review Boards at the University of North Carolina and Vidant Medical System approved all procedures and assessments.
Potential Predictors of Enrollment and Retention
We evaluated sociodemographic factors, medical factors, travel distance, and the timing of recruitment and enrollment as possible predictors of participants' attrition throughout the study.
Sociodemographic Characteristics: For nominated patients, clinical records were used to obtain data regarding race, ethnicity, sex, and age. The present analysis did not include the age of minors or their caregivers. We used the following racial categories for DOI: 10.1159/000490519 adult and child patients and for caregivers: African American, White, or Other (including people who reported more than one racial background). Ethnicity was categorized as either Hispanic/ Latino or non-Hispanic/Latino. We obtained educational level (collapsed into less than or equal to high school graduate or greater than high school graduate) and income data from the post-enrollment questionnaire; this information was available only for those who enrolled in the study and completed this study questionnaire. Annual income was reported on a 10-point scale ranging from "1" (less than USD 15,000) to "10" (USD 135,000 or more).
Medical Characteristics: Nominating clinicians identified patients as potential participants based on diagnoses, clinical features, or symptoms suggestive of a single gene condition. This information was supplemented and confirmed during the enrollment visit. Participants were then assigned to broad diagnostic categories: Cardiogenetic Disorders, Hereditary Cancer, Intellectual Disability, Neuromuscular Disorders, Hematology, Ophthalmology, and so on. Exome sequencing diagnostic results were categorized as "positive," "negative," and "uncertain." A positive result showed 1 or more gene variants that explained the health concern; a negative result showed no explanatory gene variants; and uncertain results included those in which the health concern was not fully explained by the results or in which there was uncertainty due to the interpretation of the variants.
Physical Functioning: We assessed patients' physical functioning using validated scales to evaluate whether there was a link between physical status and participation throughout the study. Adult patient participants self-reported their current level of physical functioning using an adapted version of the Karnofsky Performance Status scale [12] with an 8-point response scale ranging from 1 (ability to carry on normal activity) to 8 (severe disability and hospitalization). Caregivers reported functioning for children or cognitively impaired adults using the Functional Status Questionnaire -General [13] , which includes 14 questions assessing the frequency of behaviors indicating functioning (eat well, sleep well, act moody, seem unusually difficult) in the past 2 weeks on a scale from 0 ("Never or rarely") to 2 ("Almost always"). Responses were reverse coded as appropriate and the mean was calculated for all items. A higher score indicated worse health status. Because patient functioning was assessed using different measures for adult versus child patients or cognitively impaired adults, we calculated a z-score to standardize raw scores from the 2 measures and combined them into a single patient functioning variable.
Travel Distance: The travel distance in miles from participants' homes to their study site (UNC or Vidant) was calculated using ArcGIS online (Esri, Redlands, California). All participants' home locations were geocoded using their zip code centroid.
Time of Recruitment: Most nominees were approached for recruitment via a phone call, and invited to schedule and attend a study enrollment visit. Hematology and ophthalmology clinic patients were usually approached for recruitment and enrolled during a regularly scheduled clinic visit with a genetic counselor associated with the study.
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Adult participants and caregivers complete 45-60 min telephone survey proached, enrolled versus not enrolled, and retained versus not retained. Descriptive statistics were used to characterize each variable and its distribution, followed by bivariate associations between potential sociodemographic and related predictors and outcomes at each stage using either chi-square analyses or 2-sample t tests, depending on the data type. When more than 1 factor was associated with the dichotomous outcome at the p < 0.05 level in bivariate analysis, multivariate logistic regression analyses were conducted with a p value smaller than 0.05 considered statistically significant. All of the analyses were carried out using IBM SPSS Statistics for Windows, Version 23.0 (IBM Corp, Armonk, NY, USA).
Results
Step 1: Nominated The first stage of the cascade was the clinicians' nomination of a potential participant suspected to have a single gene disorder. Study clinicians nominated 1,147 adult and child patients. The race and ethnicity of patients nominated for the study closely reflected United States 2010 census data [14] for the state of North Carolina (White 68.5%, African American 21.5%, Hispanic 8.4%). As these individuals were not enrolled, we had no other demographic or medical data; nor did we have any sociodemographic information about caregivers of patients who were nominated but not yet enrolled. A total of 774 adult patients were nominated. They were, on average, just over 45 years old and primarily female (68.6%). The majority were non-Hispanic (90.7%) and White (67.1%). A total of 373 children or cognitively impaired adult patients were nominated. Half (51.7%) were males. The majority were non-Hispanic (82%) and White (77.2%).
Step 2: Approached for Recruitment Study team members approached 1,065 of the 1,147 patients nominated. Of the 82 nominated patients who were not approached for recruitment, 72 (88%) could not be contacted before the study closed; 9 were considered ineligible; contact information was not valid for one. A small percentage of patients (less than 10% of the total number approached) were approached for recruitment on the same day as a regularly scheduled clinic visit.
Adult Patients: Of the 774 adult patients who were nominated, 724 were approached for recruitment (online suppl. Table 2 ). In bivariate analyses, the mean age of nominees was higher in those who were approached (p = 0.026). There was no difference in the ethnicity, race, and sex of adults who were approached versus those who were not approached.
Caregivers: Of the 373 children or adults with impairment who were nominated, 341 caregivers were approached for recruitment (online suppl. Table 3 ). In bivariate analysis, there were no factors (ethnicity, race, sex) associated with this outcome and multivariate analysis was not conducted.
Step 3: Enrolled Of the 1,065 adult patients and caregivers approached for recruitment (hereafter referred to as "participants"), 645 completed the initial study visit to enroll in the study. Reasons for not enrolling included lack of interest or poor health (n = 187), inability of the study staff to schedule the enrollment visit (n = 117), failure to attend a scheduled enrollment visit ("visit incomplete") (n = 104), or patient death prior to enrollment (n = 12). Race and ethnicity were not associated with any of these reasons for not enrolling.
Adult Participants: Of the 724 adults approached, 396 enrolled in the study (Table 1) . In bivariate analyses, nominated White patients were more likely to enroll than nominated African American patients (p < 0.001). Adults who lived closer to the study site were also more likely to enroll than those who lived further away (p = 0.003). Using logistic regression to investigate the independence of potential predictors of enrollment (Table 2) , African American adults were less likely to enroll (OR 0.36; 95% CI 0.25-0.51; p < 0.001) than White adults, and adults of other races were also less likely to enroll than Whites (OR 0.49; 95% CI 0.24-0.996; p = 0.049). In addition, the likelihood of an adult enrolling in the study was reduced by 10% per 30 miles of distance to the enrollment site (OR 0.90; 95% CI 0.82-0.98; p = 0.014).
Caregivers: Of the 341 caregivers approached, 249 enrolled their dependent child or cognitively impaired adult in the study (Table 3) . In bivariate analyses, the patient's race was a predictor of enrollment (p = 0.007), but ethnicity and sex, travel distance, and method of being approached for recruitment (i.e., during a routine clinic visit compared to other means) were not significantly associated with enrolling in the study.
Travel Distance: One reason for establishing a satellite clinic at Vidant was to facilitate enrollment by not requiring patients to travel to UNC Hospitals, which is ~110 miles from Vidant's clinic facility. We compared adults approached for recruitment at UNC Hospitals with those from Vidant Medical System to determine if travel distance was a predictor for enrollment. For nominees at Vidant, the median distance from their homes to the enrollment site was 25.9 miles, while for nominees at UNC DOI: 10.1159/000490519 Hospitals, the median distance was 50.9 miles for adults and 56.3 miles for caregivers. Bivariate analyses of the adult patients at Vidant showed that travel distance from the clinic was not statistically and significantly associated with enrollment (p = 0.994). In contrast, bivariate analyses of adult patients from UNC showed a positive association between distance and enrollment (p < 0.001). As noted above, distance was not a significant predictor of enrollment by caregivers, suggesting that they may be more highly motivated.
Enrollment at Study Visits versus Regularly Scheduled Clinic Visits:
The majority of study participants from UNC were enrolled during an NCGENES-specific study visit. However, patients nominated from ophthalmology and hematology clinics (n = 80) were usually approached during a routine clinic visit. Comparing only adult patients, enrollment rates of those approached during a regularly scheduled clinic visit were higher (81%) than those who were nominated by their clinician, approached for recruitment by study staff, and then required to attend a separate, study-specific enrollment study visit (52%), meaning that adult patients were more likely to enroll with same-day recruitment (p < 0.001). Among nominees with bleeding disorders, 100% of adults and 84% of caregivers enrolled in the study. Among nominees with retinal disorders, 77% of adults and 78% of caregivers enrolled in the study. In contrast, the enrollment rate was lower among adult nominees with cardiogenetic conditions (41%) and cancer (33%) and among caregivers of child nominees who had structural anomalies (33%) and neuromuscular conditions (50%).
Step 4: Retained Throughout Study Interactions More than 6 months after enrollment, sequencing results were returned at a clinic visit, and 2 weeks later, participants completed the second telephone survey. Of the 645 enrolled participants, 46 participants were excluded because they were part of a pilot phase (n = 20), were unable to take the survey for logistical reasons (n = 6), or they had received a medically actionable secondary finding and because of study protocol were ineligible for the second survey (n = 20). Of the remaining 599 enrolled participants, 508 were retained through the completion of the second telephone survey. Adult Participants: Of the 367 enrolled adult participants who were eligible to complete the first and second telephone surveys, 310 were retained through the second telephone survey (Table 4) . In bivariate analyses, several factors were significantly associated with being less likely to be retained: African American race (p < 0.001); lower education levels (p < 0.001); and poorer physical functioning (p = 0.005). Bivariate analyses of ethnicity, age, sex, income, diagnostic result, or approach/enrollment method did not show a statistical difference between participants who were retained and those who were not. Using logistic regression to investigate the independence of potential predictors of retention (Table 5) , African Americans (OR 0.31; 95% CI 0.16-0.62; p = 0.001) were less likely to be retained than Whites, and participants with a high school or greater degree were more likely to be retained than those with less than high school education (OR 4.10; 95% CI 2.15-7.82; p < 0.001). However, physical functioning was not associated with being retained (OR 0.84; 95% CI 0.62-1.13; p = 0.247).
Caregivers: Of the 232 enrolled caregivers who were eligible to complete the telephone surveys, 198 were retained through the second survey (Table 6 ). In bivariate analyses, caregivers of White patients were more likely to be retained than caregivers of African American patients (p = 0.013); and caregivers of Hispanic patients were less likely to be retained (p < 0.001) than those of non-Hispanic or Latino patients. With regard to the caregivers themselves, White caregivers were more likely to be retained than African American caregivers (p = 0.005); those with lower education were less likely to be retained (p = 0.024); those with a higher annual income were more likely to be retained (p = 0.029); and those who enrolled at a routine clinic visit were less likely to be retained than those who enrolled at a separate enrollment visit (p = 0.026). Using logistic regression to investigate the independence of potential predictors of retention (Table 7) , caregivers were more likely to be retained when the patient's ethnicity was non-Hispanic compared to Hispanic (OR 3.71; 95% CI 1.26-11.0; p = 0.018). Race, income, education, physical functioning, and time of recruitment were not independent predictors.
Discussion
Translational research is establishing the foundation for genomic sequencing in healthcare [15] , necessitating engagement of diverse participants in order to make its application generalizable to the entire population. Many of the NCGENES study aims involved understanding psychosocial implications of genomic sequencing for patients and their families. By successfully enrolling ~30% of the participants from non-white and/or Hispanic demographic groups, we were moderately successful with our recruitment and enrollment strategies. However, Table 3 . Caregivers approached for recruitment to the NCGENES study (n = 341) and either enrolled (n = 249) or not enrolled (n = 92) there was still attrition across all stages of the study, which is expected in any complex longitudinal study requiring numerous interactions. Our goal in this analysis was to identify factors that differentially impacted attrition, to inform future research designs to achieve more broadly representative samples and results. The design of NCGENES was intended to emulate a clinical scenario in which exome sequencing was considered to be a potentially useful diagnostic test for a patient with features suggestive of a genetic disorder. Therefore, the primary eligibility criterion was the judgment of the patient's clinician (e.g., geneticist, genetic counselor, cardiologist, or neurologist) that exome sequencing might provide useful information. Similar to standard medical practice, there was likely variability in how different referring clinicians determined eligibility. Studies have demonstrated bias in the referral to genetic specialty services and/or testing initiated in the primary care or oncology settings [16] [17] [18] , but this phenomenon has not been well studied for genetics clinicians. The total population of patients nominated for NCGENES reflected the general population demographics of North Carolina, making it unlikely that significant biases existed at this stage overall, although we cannot rule out systematic differences in nomination practices among individual providers. Approximately 60% of nominees who were approached for recruitment were enrolled in the study. Half of those who declined to participate cited lack of interest or poor health, one-quarter could not be reached to schedule the enrollment visit, and one-quarter cancelled or were "noshows" for a scheduled visit. Race emerged as a significant factor accounting for differential enrollment, with African American patients being less likely to enroll. This suggests participation barriers due to the demands of everyday life and the need for alternative recruitment procedures. We found preliminary evidence that convenient enrollment protocols influenced the rate of enrollment independent of race and ethnicity. The subset of patients who were recruited by a genetic counselor during a regularly scheduled clinic visit were more likely to enroll than those who were required to attend a separate study enrollment visit. In addition, the familiarity and existing relationship with the genetic counselor may have played a role [19] .
Our enrollment of Hispanic and Latino participants representing 9.6% of the total study population, may be attributed to the use of culture-specific, patient-centered approaches [6, 20] such as reducing language barriers and being responsive to cultural differences [21] [22] [23] . We included a native Spanish-speaker on the study team, who approached eligible participants and scheduled and inter- preted their study visits. She also translated all study documents into Spanish to ensure accurate explanations of genetic concepts. Another step to increase enrollment among minorities was to partner with a community-based heart failure clinic that cares for a high proportion of African American patients, the great majority of whom had not previously had genetic testing. The rate of enrollment among African Americans from this clinic was higher than the enrollment of African Americans approached in the study. This success is attributable to familiarity with the clinic facility and team members and reduced travel burden via closer proximity and mileage reimbursement, consistent with studies demonstrating that a trusting relationship with study investigators is an important factor in the successful recruitment and enrollment of research participants [8, 19, 24, 25] . Further, although travel distance did not appear to be a barrier for enrollment at the satellite clinic or for caregivers, it was a barrier for adult nominees at the UNC site, who were less likely to enroll per each additional 30 miles they had to travel.
Thus, similar to prior studies, our data support the conclusion that offering options for enrollment at a greater number of sites, with closer proximity to the study population and with greater flexibility for same-day enrollment, could improve the enrollment rate. A possible negative consequence of same-day recruitment and enrollment, however, is the potential risk that patients may feel pressured into enrolling. To mitigate this concern, the voluntary nature of research participation should be emphasized and options for enrolling at a later time should be offered. It is also notable that caregivers of patients who were enrolled during a same-day visit were less likely to be retained, suggesting that those who enrolled at a separate study visit were more invested in the research project because of the effort they made to attend.
An innovative aspect of our study was including factors related to retention, which is quite important for the interpretation of results. The study employed several retention strategies, including regular telephone reminders to complete study activities, staff continuity, a Spanish speaking staff member who also translated result disclosure visits, and partnership with the community-based cardiology clinic to provide a convenient and familiar environment for disclosure of results. Although some of these strategies represent evidencebased recommendations [4] , much of the research about these issues focuses on bolstering recruitment and enrollment rates rather than enhancing study retention [19] . Nearly 85% of the participants in NCGENES were retained through 2 telephone surveys stretching over a period of greater than 6 months. Our endpoint for retention, the completion of the second telephone survey, was chosen because it included measures of factors such as distress, motivation to change lifestyle behaviors or use of health services, and sharing of results with others. Multivariate analysis found that African American adults and adults with lower education were significantly less likely to be retained, while Hispanic caregivers were less likely to be retained. Loss of these more vulnerable groups could affect the generalizability of our overall results.
These results extend knowledge about factors associated with retention of underrepresented groups in health research, revealing that different factors may be related to retaining adults as compared to retaining caregivers of children or cognitively impaired adult participants. Clearly, easing barriers to recruitment and enrollment do not, by themselves, guarantee successful retention, and our findings document the need to develop a broader range of approaches to achieve maximally representative study populations during all phases of a study.
Conclusions
The inclusion of diverse groups in all areas of clinical research is necessary if health equity and equal access surrounding genomic testing is to be achieved [26] . Enhancing participant diversity increases our knowledge about 
